Cargando…

Current and emerging pharmacological treatments for sarcoidosis: a review

The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Beegle, Scott H, Barba, Kerry, Gobunsuy, Romel, Judson, Marc A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627473/
https://www.ncbi.nlm.nih.gov/pubmed/23596348
http://dx.doi.org/10.2147/DDDT.S31064
_version_ 1782266315540529152
author Beegle, Scott H
Barba, Kerry
Gobunsuy, Romel
Judson, Marc A
author_facet Beegle, Scott H
Barba, Kerry
Gobunsuy, Romel
Judson, Marc A
author_sort Beegle, Scott H
collection PubMed
description The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis.
format Online
Article
Text
id pubmed-3627473
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36274732013-04-17 Current and emerging pharmacological treatments for sarcoidosis: a review Beegle, Scott H Barba, Kerry Gobunsuy, Romel Judson, Marc A Drug Des Devel Ther Review The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis. Dove Medical Press 2013-04-12 /pmc/articles/PMC3627473/ /pubmed/23596348 http://dx.doi.org/10.2147/DDDT.S31064 Text en © 2013 Beegle et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Beegle, Scott H
Barba, Kerry
Gobunsuy, Romel
Judson, Marc A
Current and emerging pharmacological treatments for sarcoidosis: a review
title Current and emerging pharmacological treatments for sarcoidosis: a review
title_full Current and emerging pharmacological treatments for sarcoidosis: a review
title_fullStr Current and emerging pharmacological treatments for sarcoidosis: a review
title_full_unstemmed Current and emerging pharmacological treatments for sarcoidosis: a review
title_short Current and emerging pharmacological treatments for sarcoidosis: a review
title_sort current and emerging pharmacological treatments for sarcoidosis: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627473/
https://www.ncbi.nlm.nih.gov/pubmed/23596348
http://dx.doi.org/10.2147/DDDT.S31064
work_keys_str_mv AT beeglescotth currentandemergingpharmacologicaltreatmentsforsarcoidosisareview
AT barbakerry currentandemergingpharmacologicaltreatmentsforsarcoidosisareview
AT gobunsuyromel currentandemergingpharmacologicaltreatmentsforsarcoidosisareview
AT judsonmarca currentandemergingpharmacologicaltreatmentsforsarcoidosisareview